Prognostic Indicators for Patients Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma †

By Yan Tristan   Brun Erwin   Cerruto Carlos   Haveric Namik   Chang David   Sugarbaker Paul  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 41-49

Springer Publishing Company

Access to resources Recommend Favorite

Diffuse Malignant Peritoneal Mesothelioma: Failure Analysis Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

By Baratti D.  

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 463-472

Springer Publishing Company

Access to resources Recommend Favorite

Morbidity and Mortality Assessment of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma—A Prospective Study of 70 Consecutive Cases

By Yan Tristan   Edwards Gary   Alderman Robert   Marquardt Christina   Sugarbaker Paul  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 515-525

Springer Publishing Company

Access to resources Recommend Favorite

In Reply: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must Be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma

By Baratti D.  

Annals of Surgical Oncology, Vol. 17, Iss. 6, 2010-06 ,pp. : 1713-1714

Springer Publishing Company

Access to resources Recommend Favorite

An Atypical Presentation of Thymoma with Diffuse Pleural Dissemination Mimicking Mesothelioma

By Vural Murat   Abali Huseyin   Oksuzoglu Berna   Akbulut Metin  

Cancer Investigation, Vol. 24, Iss. 6, 2006-09 ,pp. : 615-620

Informa Healthcare

Access to resources Recommend Favorite